Conserved RB functions in development and tumor suppression

Abstract

The variety of human cancers in which the retinoblastoma protein pRb is inactivated reflects both its broad importance for tumor suppression and its multitude of cellular functions. Accumulating evidence indicates that pRb contributes to a diversity of cellular functions, including cell proliferation, differentiation, cell death, and genome stability. pRb performs these diverse functions through the formation of large complexes that include E2F transcription factors and chromatin regulators. In this review we will discuss some of the recent advances made in understanding the structure and function of pRb as they relate to tumor suppression, and highlight research using Drosophila melanogaster that reveals important, evolutionarily conserved functions of the RB family.

Keywords

RB / E2F / Drosophila Rbf / cell cycle / chromatin modification

References

[1] Attwooll, C., Lazzerini Denchi, E., and Helin, K. (2004). The E2F family: specific functions and overlapping interests. Embo J 23, 4709–4716 .
[2] Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633–637 .
[3] Bates, S., Phillips, A.C., Clark, P.A., Stott, F., Peters, G., Ludwig, R.L., and Vousden, K.H. (1998). p14ARF links the tumour suppressors RB and p53. Nature 395, 124–125 .
[4] Benevolenskaya, E.V., Murray, H.L., Branton, P., Young, R.A., and Kaelin, W.G. Jr. (2005). Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 18, 623–635 15949438.
[5] Bergmann, A., Agapite, J., McCall, K., and Steller, H. (1998). The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 95, 331–341 9814704.
[6] Bester, A.C., Roniger, M., Oren, Y.S., Im, M.M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D.S., and Kerem, B. (2011). Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435–446 21529715.
[7] Bier, E. (2005). Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6, 9–23 15630418.
[8] Binné, U.K., Classon, M.K., Dick, F.A., Wei, W., Rape, M., Kaelin, W.G. Jr, N??r, A.M., and Dyson, N.J. (2007). Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat Cell Biol 9, 225–232 17187060.
[9] Bosco, E.E., Wang, Y., Xu, H., Zilfou, J.T., Knudsen, K.E., Aronow, B.J., Lowe, S.W., and Knudsen, E.S. (2007). The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J Clin Invest 117, 218–228 17160137.
[10] Bourgo, R.J., Thangavel, C., Ertel, A., Bergseid, J., McClendon, A.K., Wilkens, L., Witkiewicz, A.K., Wang, J.Y., and Knudsen, E.S. (2011). RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol Cell 43, 663–672 21855804.
[11] Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W., and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 9822382.
[12] Burke, J.R., Deshong, A.J., Pelton, J.G., and Rubin, S.M. (2010). Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 285, 16286–16293 20223825.
[13] Burkhart, D.L., and Sage, J. (2008). Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8, 671–682 18650841.
[14] Buttitta, L.A., Katzaroff, A.J., Perez, C.L., de la Cruz, A., and Edgar, B.A. (2007). A double-assurance mechanism controls cell cycle exit upon terminal differentiation in Drosophila. Dev Cell 12, 631–643 17419999.
[15] Calo, E., Quintero-Estades, J.A., Danielian, P.S., Nedelcu, S., Berman, S.D., and Lees, J.A. (2010). Rb regulates fate choice and lineage commitment in vivo. Nature 466, 1110–1114 20686481.
[16] Chauveinc, L., Mosseri, V., Quintana, E., Desjardins, L., Schlienger, P., Doz, F., and Dutrillaux, B. (2001). Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 22, 77–88 11449317.
[17] Chen, D., Pacal, M., Wenzel, P., Knoepfler, P.S., Leone, G., and Bremner, R. (2009a). Division and apoptosis of E2f-deficient retinal progenitors. Nature 462, 925–929 20016601.
[18] Chen, H.Z., Tsai, S.Y., and Leone, G. (2009b). Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 9, 785–797 19851314.
[19] Chicas, A., Wang, X., Zhang, C., McCurrach, M., Zhao, Z., Mert, O., Dickins, R.A., Narita, M., Zhang, M., and Lowe, S.W. (2010). Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17, 376–387 20385362.
[20] Chin, L., Hahn, W.C., Getz, G., and Meyerson, M. (2011). Making sense of cancer genomic data. Genes Dev 25, 534–555 21406553.
[21] Chong, J.L., Wenzel, P.L., Sáenz-Robles, M.T., Nair, V., Ferrey, A., Hagan, J.P., Gomez, Y.M., Sharma, N., Chen, H.Z., Ouseph, M., (2009). E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462, 930–934 20016602.
[22] Christensen, J., Agger, K., Cloos, P.A., Pasini, D., Rose, S., Sennels, L., Rappsilber, J., Hansen, K.H., Salcini, A.E., and Helin, K. (2007). RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128, 1063–1076 17320161.
[23] Claudio, P.P., Zamparelli, A., Garcia, F.U., Claudio, L., Ammirati, G., Farina, A., Bovicelli, A., Russo, G., Giordano, G.G., McGinnis, D.E., (2002). Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. Clin Cancer Res 8, 1808–1815 12060621.
[24] Coschi, C.H., Martens, A.L., Ritchie, K., Francis, S.M., Chakrabarti, S., Berube, N.G., and Dick, F.A. (2010). Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev 24, 1351–1363 20551166.
[25] Dannenberg, J.H., Schuijff, L., Dekker, M., van der Valk, M., and te Riele, H. (2004). Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 18, 2952–2962 15574596.
[26] de Nooij, J.C., Letendre, M.A., and Hariharan, I.K. (1996). A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87, 1237–1247 8980230.
[27] Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Nuciforo, P.G., Bensimon, A., (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638–642 17136094.
[28] Dick, F.A., and Mymryk, J.S. (2011). Sweet DREAMs for Hippo. Genes Dev 25, 889–894 21536729.
[29] Dimova, D.K., Stevaux, O., Frolov, M.V., and Dyson, N.J. (2003). Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev 17, 2308–2320 12975318.
[30] Du, W., and Dyson, N. (1999). The role of RBF in the introduction of G1 regulation during Drosophila embryogenesis. EMBO J 18, 916–925 10022834.
[31] Du, W., and Pogoriler, J. (2006). Retinoblastoma family genes. Oncogene 25, 5190–5200 16936737.
[32] Dynlacht, B.D., Flores, O., Lees, J.A., and Harlow, E. (1994). Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8, 1772–1786 7958856.
[33] el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 8242752.
[34] Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J., and Livingston, D.M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487–497 8343202.
[35] Feinberg, A.P., and Tycko, B. (2004). The history of cancer epigenetics. Nat Rev Cancer 4, 143–153 14732866.
[36] Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., and Lowe, S.W. (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14, 2015–2027 10950866.
[37] Ferres-Marco, D., Gutierrez-Garcia, I., Vallejo, D.M., Bolivar, J., Gutierrez-Avi?o, F.J., and Dominguez, M. (2006). Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing. Nature 439, 430–436 16437107.
[38] Firth, L.C., and Baker, N.E. (2005). Extracellular signals responsible for spatially regulated proliferation in the differentiating Drosophila eye. Dev Cell 8, 541–551 15809036.
[39] Foijer, F., Wolthuis, R.M., Doodeman, V., Medema, R.H., and te Riele, H. (2005). Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8, 455–466 16338659.
[40] Friend, S.H., Bernards, R., Rogelj, S., Weinberg, R.A., Rapaport, J.M., Albert, D.M., and Dryja, T.P. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643–646 2877398.
[41] Giangrande, P.H., Zhu, W., Schlisio, S., Sun, X., Mori, S., Gaubatz, S., and Nevins, J.R. (2004). A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev 18, 2941–2951 15574595.
[42] Ginsberg, D. (2002). E2F1 pathways to apoptosis. FEBS Lett 529, 122–125 12354623.
[43] Gonzalo, S., García-Cao, M., Fraga, M.F., Schotta, G., Peters, A.H., Cotter, S.E., Eguía, R., Dean, D.C., Esteller, M., Jenuwein, T., (2005). Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7, 420–428 15750587.
[44] Goodrich, D.W. (2003). How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein. J Cell Physiol 197, 169–180 14502556.
[45] Gordon, G.M., and Du, W. (2011). Targeting Rb inactivation in cancers by synthetic lethality. Am J Cancer Res 1, 773–786 21814623.
[46] Hallstrom, T.C., Mori, S., and Nevins, J.R. (2008). An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11–22 18167336.
[47] Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 8242751.
[48] Harrington, L.S., Findlay, G.M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N.R., Cheng, S., Shepherd, P.R., (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166, 213–223 15249583.
[49] Hassler, M., Singh, S., Yue, W.W., Luczynski, M., Lakbir, R., Sanchez-Sanchez, F., Bader, T., Pearl, L.H., and Mittnacht, S. (2007). Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol Cell 28, 371–385 17996702.
[50] Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., (2004). Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797–802 15306814.
[51] Hiebert, S.W. (1993). Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 13, 3384–3391 8497257.
[52] Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I., and Weinberg, R.A. (1992). Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993–1006 1388095.
[53] Hirschi, A., Cecchini, M., Steinhardt, R.C., Schamber, M.R., Dick, F.A., and Rubin, S.M. (2010). An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol 17, 1051–1057 20694007.
[54] Hsieh, T.C., Nicolay, B.N., Frolov, M.V., and Moon, N.S. (2010). Tuberous sclerosis complex 1 regulates dE2F1 expression during development and cooperates with RBF1 to control proliferation and survival. PLoS Genet 6, e100107120808898.
[55] Hu, N., Gutsmann, A., Herbert, D.C., Bradley, A., Lee, W.H., and Lee, E.Y. (1994). Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021–1027 8134105.
[56] Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K., Gulino, A., and Lees, J.A. (2009). Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 15, 184–194 19249677.
[57] Isaac, C.E., Francis, S.M., Martens, A.L., Julian, L.M., Seifried, L.A., Erdmann, N., Binné, U.K., Harrington, L., Sicinski, P., Bérubé, N.G., (2006). The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol 26, 3659–3671 16612004.
[58] Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., and Nevins, J.R. (2001). Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21, 4684–4699 11416145.
[59] Iwase, S., Lan, F., Bayliss, P., de la Torre-Ubieta, L., Huarte, M., Qi, H.H., Whetstine, J.R., Bonni, A., Roberts, T.M., and Shi, Y. (2007). The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077–1088 17320160.
[60] Julien, L.A., Carriere, A., Moreau, J., and Roux, P.P. (2010). mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol 30, 908–921 19995915.
[61] Kaelin, W.G. Jr. (2005). The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5, 689–698 16110319.
[62] Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F., and Sherr, C.J. (1998). Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 95, 8292–8297 9653180.
[63] Kanber, D., Berulava, T., Ammerpohl, O., Mitter, D., Richter, J., Siebert, R., Horsthemke, B., Lohmann, D., and Buiting, K. (2009). The human retinoblastoma gene is imprinted. PLoS Genet 5, e100079020041224.
[64] Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E., and Sherr, C.J. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7, 331–342 8449399.
[65] Kaye, F.J., and Harbour, J.W. (2004). For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivors. J Natl Cancer Inst 96, 342–343 14996847.
[66] Klose, R.J., Yan, Q., Tothova, Z., Yamane, K., Erdjument-Bromage, H., Tempst, P., Gilliland, D.G., Zhang, Y., and Kaelin, W.G. Jr. (2007). The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128, 889–900 17320163.
[67] Knudsen, E.S., and Wang, J.Y. (2010). Targeting the RB-pathway in cancer therapy. Clin Cancer Res 16, 1094–1099 20145169.
[68] Knudson, A.G. Jr. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68, 820–823 5279523.
[69] Korenjak, M., Taylor-Harding, B., Binné, U.K., Satterlee, J.S., Stevaux, O., Aasland, R., White-Cooper, H., Dyson, N., and Brehm, A. (2004). Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119, 181–193 15479636.
[70] Lalande, M., Dryja, T.P., Schreck, R.R., Shipley, J., Flint, A., and Latt, S.A. (1984). Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. Cancer Genet Cytogenet 13, 283–295 6210139.
[71] Lane, M.E., Sauer, K., Wallace, K., Jan, Y.N., Lehner, C.F., and Vaessin, H. (1996). Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell 87, 1225–1235 8980229.
[72] Laurie, N.A., Donovan, S.L., Shih, C.S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., (2006). Inactivation of the p53 pathway in retinoblastoma. Nature 444, 61–66 17080083.
[73] Lee, W.H., Bookstein, R., Hong, F., Young, L.J., Shew, J.Y., and Lee, E.Y. (1987). Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394–1399 3823889.
[74] Lewis, P.W., Beall, E.L., Fleischer, T.C., Georlette, D., Link, A.J., and Botchan, M.R. (2004). Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev 18, 2929–2940 15545624.
[75] Li, B., Gordon, G.M., Du, C.H., Xu, J., and Du, W. (2010). Specific killing of Rb mutant cancer cells by inactivating TSC2. Cancer Cell 17, 469–480 20478529.
[76] Li, J., Ran, C., Li, E., Gordon, F., Comstock, G., Siddiqui, H., Cleghorn, W., Chen, H.Z., Kornacker, K., Liu, C.G., (2008). Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 14, 62–75 18194653.
[77] Lin, W., Cao, J., Liu, J., Beshiri, M.L., Fujiwara, Y., Francis, J., Cherniack, A.D., Geisen, C., Blair, L.P., Zou, M.R., (2011). Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc Natl Acad Sci U S A 108, 13379–13386 21788502.
[78] Litovchick, L., Florens, L.A., Swanson, S.K., Washburn, M.P., and DeCaprio, J.A. (2011). DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev 25, 801–813 21498570.
[79] Litovchick, L., Sadasivam, S., Florens, L., Zhu, X., Swanson, S.K., Velmurugan, S., Chen, R., Washburn, M.P., Liu, X.S., and DeCaprio, J.A. (2007). Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26, 539–551 17531812.
[80] Longworth, M.S., Herr, A., Ji, J.Y., and Dyson, N.J. (2008). RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. Genes Dev 22, 1011–1024 18367646.
[81] Lopez-Bigas, N., Kisiel, T.A., Dewaal, D.C., Holmes, K.B., Volkert, T.L., Gupta, S., Love, J., Murray, H.L., Young, R.A., and Benevolenskaya, E.V. (2008). Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell 31, 520–530 18722178.
[82] Ludlow, J.W., Glendening, C.L., Livingston, D.M., and DeCarprio, J.A. (1993). Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol 13, 367–372 8380224.
[83] Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. (1995). Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503–506 7777060.
[84] Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J.P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 9468140.
[85] Manning, A.L., Longworth, M.S., and Dyson, N.J. (2010). Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev 24, 1364–1376 20551165.
[86] Milet, C., Rincheval-Arnold, A., Mignotte, B., and Guénal, I. (2010). The Drosophila retinoblastoma protein induces apoptosis in proliferating but not in post-mitotic cells. Cell Cycle 9, 97–103 20016284.
[87] Miller, C.W., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C.H., Terada, M., and Koeffler, H.P. (1992). p53 mutations in human lung tumors. Cancer Res 52, 1695–1698 1312896.
[88] Moon, N.S., Di Stefano, L., and Dyson, N. (2006). A gradient of epidermal growth factor receptor signaling determines the sensitivity of rbf1 mutant cells to E2F-dependent apoptosis. Mol Cell Biol 26, 7601–7615 16954388.
[89] Moon, N.S., Frolov, M.V., Kwon, E.J., Di Stefano, L., Dimova, D.K., Morris, E.J., Taylor-Harding, B., White, K., and Dyson, N.J. (2005). Drosophila E2F1 has context-specific pro- and antiapoptotic properties during development. Dev Cell 9, 463–475 16198289.
[90] Moroni, M.C., Hickman, E.S., Lazzerini Denchi, E., Caprara, G., Colli, E., Cecconi, F., Müller, H., and Helin, K. (2001). Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3, 552–558 11389439.
[91] Müller, H., Bracken, A.P., Vernell, R., Moroni, M.C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J.D., and Helin, K. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15, 267–285 11159908.
[92] Mulligan, G., and Jacks, T. (1998). The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 14, 223–229 9635405.
[93] Narita, M., N?nez, S., Heard, E., Narita, M., Lin, A.W., Hearn, S.A., Spector, D.L., Hannon, G.J., and Lowe, S.W. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703–716 12809602.
[94] Nicolay, B.N., Bayarmagnai, B., Islam, A.B., Lopez-Bigas, N., and Frolov, M.V. (2011). Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit. Genes Dev 25, 323–335 21325133.
[95] Nicolay, B.N., Bayarmagnai, B., Moon, N.S., Benevolenskaya, E.V., and Frolov, M.V. (2010). Combined inactivation of pRB and hippo pathways induces dedifferentiation in the Drosophila retina. PLoS Genet 6, e100091820421993.
[96] Nogueira, V., Park, Y., Chen, C.C., Xu, P.Z., Chen, M.L., Tonic, I., Unterman, T., and Hay, N. (2008). Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14, 458–470 19061837.
[97] Ozcan, U., Ozcan, L., Yilmaz, E., Düvel, K., Sahin, M., Manning, B.D., and Hotamisligil, G.S. (2008). Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29, 541–551 18342602.
[98] Pan, D. (2010). The hippo signaling pathway in development and cancer. Dev Cell 19, 491–505 20951342.
[99] Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P.P., (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207–210 10910364.
[100] Pickering, M.T., and Kowalik, T.F. (2006). Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25, 746–755 16186801.
[101] Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P., and Massagué, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 8033212.
[102] Qin, X.Q., Chittenden, T., Livingston, D.M., and Kaelin, W.G. Jr. (1992). Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6, 953–964 1534305.
[103] Racek, T., Buhlmann, S., Rüst, F., Knoll, S., Alla, V., and Pützer, B.M. (2008). Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1. J Biol Chem 283, 34305–34314 18840615.
[104] Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R.A., and Dynlacht, B.D. (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16, 245–256 11799067.
[105] Robertson, K.D., Ait-Si-Ali, S., Yokochi, T., Wade, P.A., Jones, P.L., and Wolffe, A.P. (2000). DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25, 338–342 10888886.
[106] Rogoff, H.A., Pickering, M.T., Debatis, M.E., Jones, S., and Kowalik, T.F. (2002). E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol 22, 5308–5318 12101227.
[107] Rubin, S.M., Gall, A.L., Zheng, N., and Pavletich, N.P. (2005). Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123, 1093–1106 16360038.
[108] Ruthenburg, A.J., Li, H., Patel, D.J., and Allis, C.D. (2007). Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8, 983–994 18037899.
[109] Sage, J., Miller, A.L., Pérez-Mancera, P.A., Wysocki, J.M., and Jacks, T. (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223–228 12853964.
[110] Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 15718470.
[111] Schvartzman, J.M., Duijf, P.H., Sotillo, R., Coker, C., and Benezra, R. (2011). Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701–714 21665145.
[112] Searle, J.S., Li, B., and Du, W. (2010). Targeting Rb mutant cancers by inactivating TSC2. Oncotarget 1, 228–232 20706560.
[113] Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 8259215.
[114] Shah, O.J., Wang, Z., and Hunter, T. (2004). Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14, 1650–1656 15380067.
[115] Sharma, A., Yeow, W.S., Ertel, A., Coleman, I., Clegg, N., Thangavel, C., Morrissey, C., Zhang, X., Comstock, C.E., Witkiewicz, A.K., (2010). The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120, 4478–4492 21099110.
[116] Sherr, C.J., and McCormick, F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2, 103–112 12204530.
[117] Stanelle, J., Stiewe, T., Theseling, C.C., Peter, M., and Pützer, B.M. (2002). Gene expression changes in response to E2F1 activation. Nucleic Acids Res 30, 1859–1867 11937641.
[118] Steele, L., Sukhanova, M.J., Xu, J., Gordon, G.M., Huang, Y., Yu, L., and Du, W. (2009). Retinoblastoma family protein promotes normal R8-photoreceptor differentiation in the absence of rhinoceros by inhibiting dE2F1 activity. Dev Biol 335, 228–236 19744473.
[119] Stevaux, O., Dimova, D., Frolov, M.V., Taylor-Harding, B., Morris, E., and Dyson, N. (2002). Distinct mechanisms of E2F regulation by Drosophila RBF1 and RBF2. EMBO J 21, 4927–4937 12234932.
[120] Stirzaker, C., Millar, D.S., Paul, C.L., Warnecke, P.M., Harrison, J., Vincent, P.C., Frommer, M., and Clark, S.J. (1997). Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57, 2229–2237 9187126.
[121] Stott, F.J., Bates, S., James, M.C., McConnell, B.B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K.H., (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17, 5001–5014 9724636.
[122] Sukhanova, M.J., Steele, L.J., Zhang, T., Gordon, G.M., and Du, W.. RBF and Rno promote photoreceptor differentiation onset through modulating EGFR signaling in the Drosophila developing eye. Dev Biol . Sep 2, 2011. [Epub ahead of print].
[123] Takahashi, Y., Rayman, J.B., and Dynlacht, B.D. (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14, 804–816 10766737.
[124] Talluri, S., Isaac, C.E., Ahmad, M., Henley, S.A., Francis, S.M., Martens, A.L., Bremner, R., and Dick, F.A. (2010). A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol 30, 948–960 20008551.
[125] Tanaka, H., Matsumura, I., Ezoe, S., Satoh, Y., Sakamaki, T., Albanese, C., Machii, T., Pestell, R.G., and Kanakura, Y. (2002). E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9, 1017–1029 12049738.
[126] Tanaka-Matakatsu, M., Xu, J., Cheng, L., and Du, W. (2009). Regulation of apoptosis of rbf mutant cells during Drosophila development. Dev Biol 326, 347–356 19100727.
[127] Taubert, S., Gorrini, C., Frank, S.R., Parisi, T., Fuchs, M., Chan, H.M., Livingston, D.M., and Amati, B. (2004). E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol Cell Biol 24, 4546–4556 15121871.
[128] Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Kaushik, P., Cerami, E., Reva, B., (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11–22 20579941.
[129] Thomas, D.M., Carty, S.A., Piscopo, D.M., Lee, J.S., Wang, W.F., Forrester, W.C., and Hinds, P.W. (2001). The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 8, 303–316 11545733.
[130] Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67–74 8033213.
[131] Treins, C., Warne, P.H., Magnuson, M.A., Pende, M., and Downward, J. (2010). Rictor is a novel target of p70 S6 kinase-1. Oncogene 29, 1003–1016 19935711.
[132] Tsai, K.Y., Hu, Y., Macleod, K.F., Crowley, D., Yamasaki, L., and Jacks, T. (1998). Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2, 293–304 9774968.
[133] Tsch?p, K., Conery, A.R., Litovchick, L., Decaprio, J.A., Settleman, J., Harlow, E., and Dyson, N. (2011). A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 25, 814–830 21498571.
[134] van den Heuvel, S., and Dyson, N.J. (2008). Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9, 713–724 18719710.
[135] van Harn, T., Foijer, F., van Vugt, M., Banerjee, R., Yang, F., Oostra, A., Joenje, H., and te Riele, H. (2010). Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev 24, 1377–1388 20551164.
[136] Vernier, M., Bourdeau, V., Gaumont-Leclerc, M.F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A.M., and Ferbeyre, G. (2011). Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 25, 41–50 21205865.
[137] Voas, M.G., and Rebay, I. (2003). The novel plant homeodomain protein rhinoceros antagonizes Ras signaling in the Drosophila eye. Genetics 165, 1993–2006 14704181.
[138] Wang, H., Bauzon, F., Ji, P., Xu, X., Sun, D., Locker, J., Sellers, R.S., Nakayama, K., Nakayama, K.I., Cobrinik, D., (2010). Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice. Nat Genet 42, 83–88 19966802.
[139] Wei, W., Ayad, N.G., Wan, Y., Zhang, G.J., Kirschner, M.W., and Kaelin, W.G. Jr. (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194–198 15014503.
[140] Wikenheiser-Brokamp, K.A. (2004). Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development 131, 4299–4310 15294860.
[141] Wikenheiser-Brokamp, K.A. (2006a). Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci 63, 767–780 16465443.
[142] Wikenheiser-Brokamp, K.A. (2006b). Retinoblastoma regulatory pathway in lung cancer. Curr Mol Med 6, 783–793 17100603.
[143] Williams, B.O., Remington, L., Albert, D.M., Mukai, S., Bronson, R.T., and Jacks, T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7, 480–484 7951317.
[144] Wirt, S.E., Adler, A.S., Gebala, V., Weimann, J.M., Schaffer, B.E., Saddic, L.A., Viatour, P., Vogel, H., Chang, H.Y., Meissner, A., (2010). G1 arrest and differentiation can occur independently of Rb family function. J Cell Biol 191, 809–825 21059851.
[145] Xie, W., Jiang, P., Miao, L., Zhao, Y., Zhimin, Z., Qing, L., Zhu, W.G., and Wu, M. (2006). Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res 34, 2046–2055 16617145.
[146] Yamasaki, L., Bronson, R., Williams, B.O., Dyson, N.J., Harlow, E., and Jacks, T. (1998). Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat Genet 18, 360–364 9537419.
[147] Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N.J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537–548 8653789.
[148] Young, A.P., and Longmore, G.D. (2004). Ras protects Rb family null fibroblasts from cell death: a role for AP-1. J Biol Chem 279, 10931–10938 14688262.
[149] Zhang, H.S., Gavin, M., Dahiya, A., Postigo, A.A., Ma, D., Luo, R.X., Harbour, J.W., and Dean, D.C. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79–89 10778858.
[150] Zhang, Y., Xiong, Y., and Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725–734 9529249.
[151] Zhu, L., Harlow, E., and Dynlacht, B.D. (1995). p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9, 1740–1752 7622038.